We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-2.38%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$894M
AUM Growth
-$45.6M
Cap. Flow
-$16.9M
Cap. Flow %
-1.9%
Top 10 Hldgs %
46.04%
Holding
2,887
New
179
Increased
1,150
Reduced
723
Closed
200

Sector Composition

Rank Sector Weight
1 Financials 16.87%
2 Technology 14.74%
3 Healthcare 5.91%
4 Consumer Discretionary 3.51%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIN icon
2101
Dine Brands
DIN
$452M
$2.13K ﹤0.01%
+43
New +$2.4K
AWR icon
2102
American States Water
AWR
$3.46B
$2.12K ﹤0.01%
27
-73
-73% -$6.22K
TCBI icon
2103
Texas Capital Bancshares
TCBI
$4.32B
$2.12K ﹤0.01%
36
+15
+71% +$908
AMRX icon
2104
Amneal Pharmaceuticals
AMRX
$5.79B
$2.12K ﹤0.01%
502
NAVI icon
2105
Navient
NAVI
$853M
$2.12K ﹤0.01%
123
+11
+10% +$198
OGS icon
2106
ONE Gas
OGS
$5.04B
$2.12K ﹤0.01%
31
-192
-86% -$14.5K
OWL icon
2107
Blue Owl Capital
OWL
$18.5B
$2.11K ﹤0.01%
163
+45
+38% +$537
IMVT icon
2108
Immunovant
IMVT
$8.25B
$2.11K ﹤0.01%
55
+34
+162% +$769
VCYT icon
2109
Veracyte
VCYT
$3.8B
$2.1K ﹤0.01%
94
-28
-23% -$720
CDLX icon
2110
Cardlytics
CDLX
$21.5M
$2.1K ﹤0.01%
+13
New +$1.69K
CCS icon
2111
Century Communities
CCS
$2.03B
$2.07K ﹤0.01%
31
LCTX icon
2112
Lineage Cell Therapeutics
LCTX
$278M
$2.07K ﹤0.01%
1,754
ERAS icon
2113
Erasca
ERAS
$6.39B
$2.07K ﹤0.01%
1,049
-306
-23% -$784
BLMN icon
2114
Bloomin' Brands
BLMN
$938M
$2.07K ﹤0.01%
84
-11
-12% -$292
YORW icon
2115
York Water
YORW
$514M
$2.06K ﹤0.01%
55
-27
-33% -$1.1K
CCRN
2116
DELISTED
Cross Country Healthcare
CCRN
$2.06K ﹤0.01%
83
ALLO icon
2117
Allogene Therapeutics
ALLO
$694M
$2.05K ﹤0.01%
648
-725
-53% -$3.18K
INFA
2118
DELISTED
Informatica
INFA
$2.04K ﹤0.01%
97
TBI
2119
Trueblue
TBI
$311M
$2.04K ﹤0.01%
139
+119
+595% +$1.85K
GFS icon
2120
GlobalFoundries
GFS
$29.6B
$2.04K ﹤0.01%
35
+2
+6% +$119
STER
2121
DELISTED
Sterling Check Corp. Common Stock
STER
$2.03K ﹤0.01%
161
+9
+6% +$117
FRO icon
2122
Frontline
FRO
$8.85B
$2.03K ﹤0.01%
108
NEGG icon
2123
Newegg Commerce
NEGG
$359M
$2.02K ﹤0.01%
120
+43
+56% +$999
VRTS icon
2124
Virtus Investment Partners
VRTS
$1.1B
$2.02K ﹤0.01%
10
-3
-23% -$611
CALX icon
2125
Calix
CALX
$2.39B
$2.02K ﹤0.01%
44
-15
-25% -$679

Similar funds

Lindbrook Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Lindbrook Capital held 2,887 positions worth $894M, down 4.8% from $939M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q3 2023 filing shows 179 new, 1,150 increased, 723 reduced and 200 closed positions. Its largest new stake was NuStar Energy L.P.: 17,923 shares worth $313K. The largest sale was Oaktree Specialty Lending, an estimated $7.4M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q3 2023 buy was NuStar Energy L.P.: 17,923 shares worth $313K.
  • Lindbrook Capital added most to Vanguard Morningstar Total Stock Market ETF in Q3 2023, an estimated $1.09M increase.
  • Lindbrook Capital's biggest Q3 2023 reduction was Oaktree Specialty Lending, cutting an estimated $7.4M.
  • Lindbrook Capital fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $912K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $894M portfolio in Q3 2023.
  • Lindbrook Capital opened 179 new positions and closed 200 in Q3 2023.
  • Lindbrook Capital's portfolio value fell 4.8% quarter-over-quarter to $894M.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.